Gibson PR - Search Results

1

Gibson PR. Gibson PR. J Gastroenterol Hepatol. 2017 Mar;32 Suppl 1:5-7. doi: 10.1111/jgh.13685. J Gastroenterol Hepatol. 2017. PMID: 28244673 Review.

2

Personal view: food for thought--western lifestyle and susceptibility to Crohn's disease. The FODMAP hypothesis.

Gibson PR, Shepherd SJ. Gibson PR, et al. Aliment Pharmacol Ther. 2005 Jun 15;21(12):1399-409. doi: 10.1111/j.1365-2036.2005.02506.x. Aliment Pharmacol Ther. 2005. PMID: 15948806 Free article. Review.

3

A single center experience of methotrexate in the treatment of Crohn's disease and ulcerative colitis: a case for subcutaneous administration.

Nathan DM, Iser JH, Gibson PR. Nathan DM, et al. Among authors: gibson pr. J Gastroenterol Hepatol. 2008 Jun;23(6):954-8. doi: 10.1111/j.1440-1746.2007.05006.x. Epub 2007 Jun 7. J Gastroenterol Hepatol. 2008. PMID: 17559377

4

Pilot study on the effect of reducing dietary FODMAP intake on bowel function in patients without a colon.

Croagh C, Shepherd SJ, Berryman M, Muir JG, Gibson PR. Croagh C, et al. Among authors: gibson pr. Inflamm Bowel Dis. 2007 Dec;13(12):1522-8. doi: 10.1002/ibd.20249. Inflamm Bowel Dis. 2007. PMID: 17828776

5

Dietary triggers of abdominal symptoms in patients with irritable bowel syndrome: randomized placebo-controlled evidence.

Shepherd SJ, Parker FC, Muir JG, Gibson PR. Shepherd SJ, et al. Among authors: gibson pr. Clin Gastroenterol Hepatol. 2008 Jul;6(7):765-71. doi: 10.1016/j.cgh.2008.02.058. Epub 2008 May 5. Clin Gastroenterol Hepatol. 2008. PMID: 18456565 Clinical Trial.

6

Probiotic effects on intestinal fermentation patterns in patients with irritable bowel syndrome.

Barrett JS, Canale KE, Gearry RB, Irving PM, Gibson PR. Barrett JS, et al. Among authors: gibson pr. World J Gastroenterol. 2008 Aug 28;14(32):5020-4. doi: 10.3748/wjg.14.5020. World J Gastroenterol. 2008. PMID: 18763284 Free PMC article. Clinical Trial.

7

Overview of inflammatory bowel disease in Australia in the last 50 years.

Gibson PR. Gibson PR. J Gastroenterol Hepatol. 2009 Oct;24 Suppl 3:S63-8. doi: 10.1111/j.1440-1746.2009.06073.x. J Gastroenterol Hepatol. 2009. PMID: 19799701 Review.

8

Evidence-based dietary management of functional gastrointestinal symptoms: The FODMAP approach.

Gibson PR, Shepherd SJ. Gibson PR, et al. J Gastroenterol Hepatol. 2010 Feb;25(2):252-8. doi: 10.1111/j.1440-1746.2009.06149.x. J Gastroenterol Hepatol. 2010. PMID: 20136989 Review.

9

Manipulation of dietary short chain carbohydrates alters the pattern of gas production and genesis of symptoms in irritable bowel syndrome.

Ong DK, Mitchell SB, Barrett JS, Shepherd SJ, Irving PM, Biesiekierski JR, Smith S, Gibson PR, Muir JG. Ong DK, et al. Among authors: gibson pr. J Gastroenterol Hepatol. 2010 Aug;25(8):1366-73. doi: 10.1111/j.1440-1746.2010.06370.x. J Gastroenterol Hepatol. 2010. PMID: 20659225 Clinical Trial.

10

Diarrhoea during enteral nutrition is predicted by the poorly absorbed short-chain carbohydrate (FODMAP) content of the formula.

Halmos EP, Muir JG, Barrett JS, Deng M, Shepherd SJ, Gibson PR. Halmos EP, et al. Among authors: gibson pr. Aliment Pharmacol Ther. 2010 Oct;32(7):925-33. doi: 10.1111/j.1365-2036.2010.04416.x. Aliment Pharmacol Ther. 2010. PMID: 20670219 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

466 results

Search Page